DSG3 and acquired polycythemia vera: Ellebrecht et al introduced the binding domain of Dsg3 in CAAR-T cell surface and significantly attenuated the release of PV-associated autoantibodies and the degree of pathological syndrome (Ellebrecht et al., 2016).